Author:
Shi Ting,Bian Yuanxi,Wu Jiahui,Li Xiaohong,Deng Jianping,Feng Tao,Huang Linlin,Kong Xiaoxing,Tian Jianmei
Abstract
Abstract
Background
The neurological symptoms caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of increasing concern. Convulsions are among the main neurological manifestations reported in children with coronavirus disease-2019 (COVID-19), and cause serious harm to physical and mental health. This study aimed to investigate the risk factors for convulsion in children with COVID-19.
Methods
This prospective study was conducted at the Children’s Hospital of Soochow University. In total, 102 COVID-19 patients with convulsion, 172 COVID-19 patients without convulsion, and 50 healthy controls were enrolled in the study. The children’s clinical and laboratory data were analyzed to assess the risk factors for convulsion in COVID-19 patients.
Results
Convulsions occurred in 37.2% of children, mostly those aged 1–3 years, who were hospitalized with the Omicron variant. The neutrophil count, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume-to-platelet ratio (MPR) were significantly higher in the convulsion group than those in the non-convulsion and control groups (P < 0.01). However, the counts of lymphocytes, eosinophils, platelets, lymphocyte subsets, CD3+ T cells, CD4+ T cells, CD8+ T cells, and NK cells were lower in the convulsion group than those in the non-convulsion and control groups (P < 0.01). Multivariate regression analysis indicated that NK cell count (OR = 0.081, 95% CI: 0.010–0.652) and a history of febrile seizure (OR = 10.359, 95% CI: 2.115–50.746) were independent risk factors for the appearance of convulsions in COVID-19.
Conclusions
History of febrile seizure and decreased NK cell count were high-risk factors for convulsions in COVID-19 patients.
Funder
Science and Technology Program of Suzhou
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Word Health Organization. Weekly epidemiological update on COVID-19–4 January2023[EB/OL].(2023–01–04)[2023–01–12]. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---4-january-2023.
2. Chinese Center for Disease Control and Prevention. There are several things you need to know about BQ. 1[EB/OL].(2022–12–13)[2023–01–05]. https://www.chinacdc.cn/yyrdgz/202212/t20221213_263008.html.
3. CDC COVID-19 Response Team, Jorden MA, Rudman SL, et al. Evidence for Limited Early Spread of COVID-19 Within the United States, January-February 2020. MMWR Morb Mortal Wkly Rep. 2020. 69(22): 680–684.
4. Fink EL, Robertson CL, Wainwright MS, et al. Prevalence and risk factors of neurologic manifestations in hospitalized children diagnosed with acute SARS-CoV-2 or MIS-C. Pediatr Neurol. 2022;128:33–44.
5. Misra S, Kolappa K, Prasad M, et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology. 2021;97(23):e2269–81.